Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00975520 · ClinicalTrials.gov registry record · NA
Neurotropic Melanoma of the Head and Neck
A NA study, sponsored by Melanoma and Skin Cancer Trials Limited.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00975520 is a NA study that has completed, run by Melanoma and Skin Cancer Trials Limited. The registered enrollment target is 50 participants.
The verdict
NCT00975520, a NA study, has completed, sponsored by Melanoma and Skin Cancer Trials Limited.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a 2-armed randomised controlled trial comparing surgery alone with surgery plus post-operative radiation therapy for patients with completely resected primary melanoma showing histological features of neurotropism. Uncontrolled studies suggest that this form of primary melanoma has a high risk of local recurrence and that postoperative radiation therapy may substantially reduce that risk. Patients who are eligible on the basis of the pathology of the excised melanoma will be offered the opportunity to take part in the trial. Those randomised to receive radiation therapy will be treated with a simple technique encompassing the surgical bed plus a margin. Radiation will commence within 3 months of surgery (maximum of 14 weeks from surgery to start of radiotherapy).
Interventions
- OTHER Observation
- RADIATION Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-09 |
| Est. Completion | 2023-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00975520
The ClinicalTrials.gov registry entry for NCT00975520 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Melanoma and Skin Cancer Trials Limited, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Observation is the first listed.
NCT00975520 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00975520 about?
NCT00975520 is a clinical study titled "Neurotropic Melanoma of the Head and Neck". This is a 2-armed randomised controlled trial comparing surgery alone with surgery plus post-operative radiation therapy for patients with completely resected primary melanoma showing histological features of neurotropism. Uncontrolled studies suggest that this form of primary melanoma has a high ri...
What is the current status of trial NCT00975520?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2009-09. Estimated completion is 2023-03.
What interventions are being tested in trial NCT00975520?
The interventions under investigation include: Observation (OTHER), Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT00975520?
This trial is sponsored by Melanoma and Skin Cancer Trials Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.